SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing significant volatility and trending downward after investors reacted negatively to conservative guidance and ongoing concerns about soft sales in China, despite the company posting a double earnings beat. The community is deeply divided, with many retail investors labeling the brand as 'stale' or 'woke' while others view the depressed price as a generational buying opportunity for a long-term turnaround.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched Tema Space Innovators ETF (NASA) is drawing significant attention as traders debate whether its small asset base and exposure to SpaceX represent a promising new momentum play or a potential risk. Community discussion is sharply divided, with some investors eyeing the ticker for its high-volatility potential and similarities to recent thematic ETF surges, while others express skepticism over its low assets under management and limited holdings.

Ganymede

Ganymede is drawing attention as market participants highlight its clean structural formation and consistent buyer interest, fueling community optimism about its potential for growth. Traders are actively discussing the token's quiet momentum and controlled price action, viewing current levels as a favorable accumulation phase.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is seeing intense community debate as investors weigh its status as a battle-tested DeFi protocol against significant price volatility and concerns over governance efficacy. While some holders point to a capped supply and potential for V4 protocol updates as a catalyst for a rebound, many participants are expressing frustration over persistent downward pressure and are actively comparing its performance to competitors like AAVE.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for community discussion as investors debate its long-term potential amid significant leadership changes and a shift toward U.S.-based institutional operations. While some users express frustration over stagnant price action and recent market lows, a vocal segment of the community remains focused on the project's real-world utility, recent regulatory clarity, and its ongoing efforts to scale institutional adoption.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors digest the commercial launch of Yartemlea following recent FDA approval and look ahead to upcoming earnings for initial revenue insights. Community discussion remains focused on the company's strong cash position, the strategic potential of the Novo Nordisk partnership, and anticipation of a potential squeeze as market participants weigh long-term value against ongoing short interest.

Maul Coin

Maul Coin is currently trending as the community rallies to drive organic growth through coordinated promotion and social media engagement, aiming to push the project to higher market cap milestones. Investors are actively discussing the importance of holding, community-led burning mechanisms, and the push for official chart integration to establish long-term legitimacy.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh recent strategic growth initiatives, including new commercialization partnerships in the metabolic and obesity drug space, against broader concerns regarding patent cliffs and shifting demand in its core vaccine segment. The community is actively discussing the stock's long-term potential as a dividend-paying value play while closely monitoring its oncology pipeline and speculative M&A sentiment within the biotech sector.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom is currently at the center of intense debate among retail traders who are vocally frustrated by stagnant price action and perceived market manipulation, while technical analysts closely monitor critical support levels and potential gap-fill opportunities following the company's recent product developments. The community is actively debating whether the stock is an oversold buying opportunity poised for a technical bounce or a fundamental value trap facing continued institutional selling pressure.

Applied Digital Corporation

Applied Digital is experiencing extreme volatility as investors weigh the company's long-term AI infrastructure potential against a broader market sell-off triggered by geopolitical uncertainty. The community is actively debating whether to treat the current pullback as a deep-value buying opportunity ahead of upcoming earnings or to prepare for further downside amid concerns regarding market-wide risk-off sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>For Q4 2025, GE Vernova reported a better-than-expected revenue of $10.96 billion</li><li>Net income came in at $3.7 billion, supported by a $2.9 billion tax benefit.</li><li>China Renaissance initiated stock coverage with a ‘Buy’ rating and a price target of $966.</li></ul>GE Vernova (GEV) on Wednesday raised its full-year 2026 and 2028 revenue guidance, following regulatory approval for the acquisition of Prolec GE, which is expected to close on Feb. 2, 2026.For FY 2026, the company now forecasts revenue of $44 billion to $45 billion, up from $41 billion to $42 billion, with an adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin of 11% to 13%.&nbsp;Segment-wise, Power is expected to deliver 16% to 18% organic revenue growth with margins of 16% to 18%. Wind revenue is projected to decline at a low double-digit rate, with an EBITDA loss of around $400 million, while Electrification revenue is seen at $13.5 billion to $14 billion, including roughly $3 billion from Prolec GE.Looking ahead to FY2028, the company now targets $56 billion in revenue, up from the $52 billion it had forecast earlier.<h2 class="st-heading-2">Q4 Results</h2>For Q4 2025, GE Vernova reported revenue of $10.96 billion, up 4%, and above Wall Street estimates of $10.22 billion, according to Fiscal.ai data. Net income came in at $3.7 billion, supported by a $2.9 billion tax benefit. &nbsp;The company also declared a quarterly dividend of $0.50 per share.<a href="https://stocktwits.com/symbol/GEV">GEV stock</a> was down nearly 3% in pre-market trading but climbed marginally higher after the opening bell.“Given our strong free cash flow generation, we ended the quarter with a healthy cash balance of nearly $9 billion, which continues to give us confidence to invest in our core businesses and return cash to shareholders through our share repurchase actions and quarterly dividend payment, while maintaining a strong investment grade balance sheet,” said&nbsp;GE Vernova CFO&nbsp;Ken Parks.&nbsp;Separately, China Renaissance initiated coverage of GE Vernova with a ‘Buy’ rating and a price target of $966.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘neutral,’ amid ‘extremely high’ message volumes.One user spoke about the stock’s steady upside move.<stembedurl>https://stocktwits.com/terrin07/message/643149766</stembedurl>One user speculated on why the stock's movement didn’t align with the overall earnings.<stembedurl>https://stocktwits.com/Mahvalousday/message/643119968</stembedurl>The stock has gained over 97% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the GE Vernova company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Why Is GEV Stock Drawing Investor Attention Today?

GE Vernova now expects 2026 revenue of $44–$45 billion, up from $41–$42 billion, and lifted its 2028 revenue target to $56 billion from $52 billion.

Equity

Rising demand for 2x Leveraged Daily ETFs tied to AI infrastructure stocks such as CoreWeave and NuScale PowerNEW YORK, July 24, 2025 /PRNewswire/ -- <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4473963-1&amp;h=1914267937&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs%2C">Tradr ETFs,</a> a provider of ETFs designed for sophisticated investors and professional traders, today announced that options trading is now available on its five newest leveraged ETFs: the Tradr 2X Long CRWV Daily ETF (Cboe: CWVX), the Tradr 2X Long SMR Daily ETF (Cboe: SMU), the Tradr 2X Long ASTS Daily ETF (Cboe: ASTX), the Tradr 2X Long GEV Daily ETF (Cboe: GEVX), and the Tradr 2X Long CEG Daily ETF (Cboe: CEGX).The five ETFs, all first-to-market products launched on July 11, have rapidly gained traction among traders seeking 200% daily long exposure to highly watched and liquid single stocks. Four of those names, CoreWeave (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">CRWV</a>), NuScale Power (NYSE: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">SMR</a>), GE Vernova (NYSE: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">GEV</a>) and Constellation Energy (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">CEG</a>), are tied to the AI buildout theme, while AST SpaceMobile (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">ASTS</a>) is setting the standard for a global satellite network focused on mobile phone users."In&nbsp;just&nbsp;eight&nbsp;trading days,&nbsp;these&nbsp;five&nbsp;ETFs&nbsp;have&nbsp;accumulated&nbsp;over&nbsp;$60&nbsp;million in&nbsp;assets&nbsp;which&nbsp;we&nbsp;believe really validates the thirst investors have for these types of long exposures," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "With the start of options trading, traders have even more choice to amplify their high-conviction ideas on five very exciting stocks."For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4473963-1&amp;h=849917014&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4473963-1&amp;h=4234011838&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr%C2%A0ETFs">Tradr&nbsp;ETFs</a>&nbsp;are designed&nbsp;for&nbsp;sophisticated&nbsp;investors and&nbsp;professional traders&nbsp;who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT&nbsp;RISK&nbsp;INFORMATIONTradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier&nbsp;than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4473963-1&amp;h=849917014&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed&nbsp;by&nbsp;ALPS&nbsp;Distributors,&nbsp;Inc,&nbsp;which&nbsp;is&nbsp;not&nbsp;affiliated&nbsp;with&nbsp;AXS&nbsp;Investments&nbsp;or&nbsp;its&nbsp;Tradr&nbsp;ETFs.&nbsp;AXI000718SOURCE Tradr ETFsNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit the article.

Options Trading Now Available on Latest Five Tradr ETFs: CWVX, SMU, ASTX, GEVX and CEGX

https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html

Others

Investment Managers Series Trust II - Tradr 2X Long GEV Daily ETF

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

GEVX
Tradr 2X Long GEV Daily ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest GEVX News

GEVXTradr 2X Long GEV Daily ETF